Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study.

Michael H RivnerBrandy M QuarlesJin-Xiu PanZheng YuJames F HowardAndrea CorseMazen M DimachkieCarlayne JacksonTuan VuGeorge SmallRobert P LisakJerry BelshIkjae LeeRichard J NowakVanessa BauteStephen ScelsaJ Americo FernandesZachary SimmonsAndrea SwensonRichard BarohnR Bhavaraju SankaClifton GoochEroboghene UboguJames CaressMamatha PasnoorHongyan XuLin Mei

Published in: Muscle & nerve (2020)

Antibody-positive patients had more severe clinical disease than antibody-negative patients. Most DNMG patients responded to standard therapy regardless of antibody status.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
early onset
bone marrow
patient reported